LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE

被引：0
|
作者：
Cacciapaglia, F. [1 ,2 ]
Anelli, M. G. [3 ]
Rinaldi, A. [3 ]
Serafino, L. [3 ]
Coladonato, L. [3 ]
Covelli, M. [3 ]
Scioscia, C. [3 ]
Iannone, F. [3 ]
Lapadula, G. [3 ]
机构：
[1] N Melli Hosp, Internal Med Unit, San Pietro Vco, BR, Italy
[2] N Melli Hosp, Rheumatol Clin, San Pietro Vco, BR, Italy
[3] Univ Med Sch Bari, Rheumatol Unit, Bari, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：229 / 229
页数：1
相关论文
共 50 条
  • [21] Safety of anti-TNF-alpha therapy in patients with rheumatoid arthritis and chronic hcv infection
    Ferri, C.
    Ferraccioli, G.
    Ferrari, D.
    Galeazzi, M.
    Lapadula, G.
    Montecucco, C.
    Valentini, G.
    Valesini, G.
    Gisea
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 169 - 169
  • [22] Infliximab (Anti-TNF-alpha antibody) improved insulin resistance in rheumatoid arthritis patients
    Sayo, Y
    Dobashi, H
    Matubara, S
    Tada, S
    Taminato, T
    Ishida, T
    DIABETES, 2005, 54 : A149 - A149
  • [23] Insulin resistance in rheumatoid arthritis: the impact of anti-TNF-alpha therapy
    Gonzalez-Gay, Miguel A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (02) : 184 - 184
  • [24] Predictors of discontinuation of anti-TNF-alpha therapy in rheumatoid arthritis.
    Agarwal, SK
    Shadick, NA
    Karlson, EW
    Glass, RJ
    Maher, NE
    Weinblatt, ME
    Solomon, DH
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4086 - 4087
  • [25] Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody infliximab - A prospective study
    Lange, U
    Teichmann, J
    Strunk, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 443 - 444
  • [26] NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-alpha monoclonal antibody therapy
    KaldenNemeth, D
    Grebmeier, J
    Antoni, C
    Manger, B
    Wolf, F
    Kalden, JR
    RHEUMATOLOGY INTERNATIONAL, 1997, 16 (06) : 249 - 255
  • [27] T CELLS EXPANSION IN RHEUMATOID AND PSORIATIC ARTHRITIS PATIENTS UNDER ANTI-TNF-ALPHA AGENTS
    Picchianti-Diamanti, A.
    Rosado, M. M.
    Pilozzi, E.
    Markovic, M.
    D'Amelio, R.
    Lagana, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 489 - 489
  • [28] Pharmacokinetics and pharmacodynamics of a human anti-TNF-alpha monoclonal antibody in patients with rheumatoid arthritis.
    Jang, H
    Marini, JC
    Pendley, C
    Jiao, Q
    Marciniak, SJ
    Cohen, S
    Fleischmann, R
    Everitt, DE
    Davis, HM
    Graham, MA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P53 - P53
  • [29] GOLIMUMAB, A HUMAN TNF-ALPHA μONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF-ALPHA AGENTS (GO-AFTER STUDY)
    Wordsworth, Paul
    Smolen, Josef
    Kay, Jonathan
    Doyle, Mittie K.
    Landewe, Robert
    Matteson, Eric L.
    Zhou, Y.
    Hsia, E. C.
    Rahman, M. U.
    RHEUMATOLOGY, 2009, 48 : I18 - I18
  • [30] Transcriptome analysis in rheumatoid arthritis following anti-TNF-alpha (enbrel®) therapy
    Kekow, J
    Drynda, S
    Koczan, D
    Thiesen, HJ
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 76 - 76
12345